A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

The core symptoms of autism spectrum disorder (ASD) include impaired social communication, repetitive behaviors, and restricted interests. No effective pharmacotherapy for these core deficits exists. Within the domain of social communication, the vasopressin system is implicated in social cognition...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuropsychopharmacology
Asıl Yazarlar: Umbricht, Daniel, del Valle Rubido, Marta, Hollander, Eric, McCracken, James T, Shic, Frederick, Scahill, Lawrence, Noeldeke, Jana, Boak, Lauren, Khwaja, Omar, Squassante, Lisa, Grundschober, Christophe, Kletzl, Heidemarie, Fontoura, Paulo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520775/
https://ncbi.nlm.nih.gov/pubmed/27711048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2016.232
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller